SearcharxivSearch

arXiv subjects

Raquibul Hannan

Publications and source records attributed to Raquibul Hannan.

9 recordsLinked to original sources

Exploring Strategies for Personalized Radiation Therapy Part IV: An Interaction-Picture Approach to Quantify the Abscopal Effect

We revisit the controversial "abscopal" effect in the context of Personalized Ultra-Fractionated Stereotactic Adaptive Radiotherapy (PULSAR). By allowing long interval between fractions, PULSAR may enhance systemic immune activation and increase the likelihood of abscopal responses compared with conventional daily fractionation. To quantify treatment-induced effects, we introduce an interaction-picture transformation adapted from quantum mechanics, which separates intrinsic tumor growth from radiation and immune-mediated perturbations. In this preliminary study, we tested this method to two preclinical bilateral tumor models (4T1 and MC38). Our model provides a quantitative measure of the interaction strength between primary and secondary tumors at the individual level, capturing dynamics over time rather than relying solely on cohort averages. This approach frames the abscopal effect as a continuous, stochastic phenomenon rather than a binary response. The framework is flexible for future studies, particularly in concurrent radiation and immunotherapy with PULSAR, where different radiation doses and fractionation schedules can be compared, and immune checkpoint inhibitors (ICIs) can be incorporated to further enhance systemic anti-tumor immunity. The framework can also help us make cross-study comparison of abscopal effects and standardizes the reporting of abscopal magnitude beyond simple statistical significance.

q-bio.QM

A multimodal ensemble approach for clear cell renal cell carcinoma treatment outcome prediction

Purpose: A reliable cancer prognosis model for clear cell renal cell carcinoma (ccRCC) can enhance personalized treatment. We developed a multi-modal ensemble model (MMEM) that integrates pretreatment clinical data, multi-omics data, and histopathology whole slide image (WSI) data to predict overall survival (OS) and disease-free survival (DFS) for ccRCC patients. Methods: We analyzed 226 patients from The Cancer Genome Atlas Kidney Renal Clear Cell Carcinoma (TCGA-KIRC) dataset, which includes OS, DFS follow-up data, and five data modalities: clinical data, WSIs, and three multi-omics datasets (mRNA, miRNA, and DNA methylation). Separate survival models were built for OS and DFS. Cox-proportional hazards (CPH) model with forward feature selection is used for clinical and multi-omics data. Features from WSIs were extracted using ResNet and three general-purpose foundation models. A deep learning-based CPH model predicted survival using encoded WSI features. Risk scores from all models were combined based on training performance. Results: Performance was assessed using concordance index (C-index) and AUROC. The clinical feature-based CPH model received the highest weight for both OS and DFS tasks. Among WSI-based models, the general-purpose foundation model (UNI) achieved the best performance. The final MMEM model surpassed single-modality models, achieving C-indices of 0.820 (OS) and 0.833 (DFS), and AUROC values of 0.831 (3-year patient death) and 0.862 (cancer recurrence). Using predicted risk medians to stratify high- and low-risk groups, log-rank tests showed improved performance in both OS and DFS compared to single-modality models. Conclusion: MMEM is the first multi-modal model for ccRCC patients, integrating five data modalities. It outperformed single-modality models in prognostic ability and has the potential to assist in ccRCC patient management if independently validated.

cs.CV

Performance Deterioration of Deep Learning Models after Clinical Deployment: A Case Study with Auto-segmentation for Definitive Prostate Cancer Radiotherapy

We evaluated the temporal performance of a deep learning (DL) based artificial intelligence (AI) model for auto segmentation in prostate radiotherapy, seeking to correlate its efficacy with changes in clinical landscapes. Our study involved 1328 prostate cancer patients who underwent definitive radiotherapy from January 2006 to August 2022 at the University of Texas Southwestern Medical Center. We trained a UNet based segmentation model on data from 2006 to 2011 and tested it on data from 2012 to 2022 to simulate real world clinical deployment. We measured the model performance using the Dice similarity coefficient (DSC), visualized the trends in contour quality using exponentially weighted moving average (EMA) curves. Additionally, we performed Wilcoxon Rank Sum Test to analyze the differences in DSC distributions across distinct periods, and multiple linear regression to investigate the impact of various clinical factors. The model exhibited peak performance in the initial phase (from 2012 to 2014) for segmenting the prostate, rectum, and bladder. However, we observed a notable decline in performance for the prostate and rectum after 2015, while bladder contour quality remained stable. Key factors that impacted the prostate contour quality included physician contouring styles, the use of various hydrogel spacer, CT scan slice thickness, MRI-guided contouring, and using intravenous (IV) contrast. Rectum contour quality was influenced by factors such as slice thickness, physician contouring styles, and the use of various hydrogel spacers. The bladder contour quality was primarily affected by using IV contrast. This study highlights the challenges in maintaining AI model performance consistency in a dynamic clinical setting. It underscores the need for continuous monitoring and updating of AI models to ensure their ongoing effectiveness and relevance in patient care.

eess.IV

Dosimetric impact of physician style variations in contouring CTV for post-operative prostate cancer: A deep learning-based simulation study

Inter-observer variation is a significant problem in clinical target volume(CTV) segmentation in postoperative settings, where there is no gross tumor present. In this scenario, the CTV is not an anatomically established structure, but one determined by the physician based on the clinical guideline used, the preferred tradeoff between tumor control and toxicity, their experience and training background, and other factors. This results in high inter-observer variability between physicians. This variability has been considered an issue, but the absence of multiple physician CTV contours for each patient and the significant amount of time required for dose planning have made it impractical to study its dosimetric consequences. In this study, we analyze the impact that variations in physician style have on dose to organs-at-risk(OAR) by simulating the clinical workflow via deep learning. For a given patient previously treated by one physician, we use deep learning-based tools to simulate how other physicians would contour the CTV and how the corresponding dose distributions would look for this patient. To simulate multiple physician styles, we use a previously developed in-house CTV segmentation model that can produce physician style-aware segmentations. The corresponding dose distribution is predicted using another in-house deep learning tool, which, can predict dose within 3% of the prescription dose, on average, on the test data. For every test patient, four different physician style CTVs are considered, and four different dose distributions are analyzed. OAR dose metrics are compared, showing that even though physician style variations result in organs getting different doses, all the important dose metrics except Maximum Dose point are within the clinically acceptable limit.

physics.med-ph

Fully Automated Organ Segmentation in Male Pelvic CT Images

Accurate segmentation of prostate and surrounding organs at risk is important for prostate cancer radiotherapy treatment planning. We present a fully automated workflow for male pelvic CT image segmentation using deep learning. The architecture consists of a 2D localization network followed by a 3D segmentation network for volumetric segmentation of prostate, bladder, rectum, and femoral heads. We used a multi-channel 2D U-Net followed by a 3D U-Net with encoding arm modified with aggregated residual networks, known as ResNeXt. The models were trained and tested on a pelvic CT image dataset comprising 136 patients. Test results show that 3D U-Net based segmentation achieves mean (SD) Dice coefficient values of 90 (2.0)% ,96 (3.0)%, 95 (1.3)%, 95 (1.5)%, and 84 (3.7)% for prostate, left femoral head, right femoral head, bladder, and rectum, respectively, using the proposed fully automated segmentation method.

physics.med-ph

PSA-Net: Deep Learning based Physician Style-Aware Segmentation Network for Post-Operative Prostate Cancer Clinical Target Volume

Automatic segmentation of medical images with DL algorithms has proven to be highly successful. With most of these algorithms, inter-observer variation is an acknowledged problem, leading to sub-optimal results. This problem is even more significant in post-operative clinical target volume (post-op CTV) segmentation due to the absence of macroscopic visual tumor in the image. This study, using post-op CTV segmentation as the test bed, tries to determine if physician styles are consistent and learnable, if there is an impact of physician styles on treatment outcome and toxicity; and how to explicitly deal with physician styles in DL algorithms to facilitate its clinical acceptance. A classifier is trained to identify which physician has contoured the CTV from just the contour and corresponding CT scan, to determine if physician styles are consistent and learnable. Next, we evaluate if adapting automatic segmentation to physician styles would be clinically feasible based on a lack of difference between outcomes. For modeling different physician styles of CTV segmentation, a concept called physician style-aware (PSA) segmentation is proposed which is an encoder-multidecoder network trained with perceptual loss. With the proposed physician style-aware network (PSA-Net), Dice similarity coefficient (DSC) accuracy increases on an average of 3.4% for all physicians from a general model that is not style adapted. We show that stylistic contouring variations also exist between institutions that follow the same segmentation guidelines and show the effectiveness of the proposed method in adapting to new institutional styles. We observed an accuracy improvement of 5% in terms of DSC when adapting to the style of a separate institution.

cs.CV

A deep learning-based framework for segmenting invisible clinical target volumes with estimated uncertainties for post-operative prostate cancer radiotherapy

In post-operative radiotherapy for prostate cancer, the cancerous prostate gland has been surgically removed, so the clinical target volume (CTV) to be irradiated encompasses the microscopic spread of tumor cells, which cannot be visualized in typical clinical images such as computed tomography or magnetic resonance imaging. In current clinical practice, physicians segment CTVs manually based on their relationship with nearby organs and other clinical information, per clinical guidelines. Automating post-operative prostate CTV segmentation with traditional image segmentation methods has been a major challenge. Here, we propose a deep learning model to overcome this problem by segmenting nearby organs first, then using their relationship with the CTV to assist CTV segmentation. The model proposed is trained using labels clinically approved and used for patient treatment, which are subject to relatively large inter-physician variations due to the absence of a visual ground truth. The model achieves an average Dice similarity coefficient (DSC) of 0.87 on a holdout dataset of 50 patients, much better than established methods, such as atlas-based methods (DSC<0.7). The uncertainties associated with automatically segmented CTV contours are also estimated to help physicians inspect and revise the contours, especially in areas with large inter-physician variations. We also use a 4-point grading system to show that the clinical quality of the automatically segmented CTV contours is equal to that of approved clinical contours manually drawn by physicians.

eess.IV

Reliable Gene Mutation Prediction in Clear Cell Renal Cell Carcinoma through Multi-classifier Multi-objective Radiogenomics Model

Genetic studies have identified associations between gene mutations and clear cell renal cell carcinoma (ccRCC). Because the complete gene mutational landscape cannot be characterized through biopsy and sequencing assays for each patient, non-invasive tools are needed to determine the mutation status for tumors. Radiogenomics may be an attractive alternative tool to identify disease genomics by analyzing amounts of features extracted from medical images. Most current radiogenomics predictive models are built based on a single classifier and trained through a single objective. However, since many classifiers are available, selecting an optimal model is difficult. On the other hand, a single objective may not be a good measure to guide model training. We proposed a new multi-classifier multi-objective (MCMO) radiogenomics predictive model. To obtain more reliable prediction results, similarity-based sensitivity and specificity were defined and considered as the two objective functions simultaneously during training. To take advantage of different classifiers, the evidential reasoning (ER) approach was used for fusing the output of each classifier. Additionally, a new similarity-based multi-objective optimization algorithm (SMO) was developed for training the MCMO to predict ccRCC related gene mutations (VHL, PBRM1 and BAP1). Preliminary results revealed an association between some quantitative computed tomography (CT) features and underlying mutations. Using the proposed MCMO model, we achieved a predictive area under the receiver operating characteristic curve (AUC) over 0.86 for VHL, PBRM1, and BAP1 genes with balanced sensitivity and specificity. Furthermore, MCMO outperformed all the individual classifiers and yielded more reliable results than other optimization algorithms and commonly used fusion strategies.

physics.med-ph

Segmentation of the prostate and organs at risk in male pelvic CT images using deep learning

Inter-and intra-observer variation in delineating regions of interest (ROIs) occurs because of differences in expertise level and preferences of the radiation oncologists. We evaluated the accuracy of a segmentation model using the U-Net structure to delineate the prostate, bladder, and rectum in male pelvic CT images. The dataset used for training and testing the model consisted of raw CT scan images of 85 prostate cancer patients. We designed a 2D U-Net model to directly learn a mapping function that converts a 2D CT grayscale image to its corresponding 2D OAR segmented image. Our network contains blocks of convolution 2D layers with variable kernel sizes, channel number, and activation functions. On the left side of the U-Net model, we used three 3x3 convolutions, each followed by a rectified linear unit (ReLu) (activation function), and one max pooling operation. On the right side of the U-Net model, we used a 2x2 transposed convolution and two 3x3 convolution networks followed by a ReLu activation function. The automatic segmentation using the U-Net generated an average dice similarity coefficient (DC) and standard deviation (SD) of the following: DC +- SD (0.88 +- 0.12), (0.95 +- 0.04), and (0.92 +- 0.06) for the prostate, bladder, and rectum, respectively. Furthermore, the mean of average surface Hausdorff distance (ASHD) and SD were 1.2 +- 0.9 mm, 1.08 +- 0.8 mm, and 0.8 +- 0.6 mm for the prostate, bladder, and rectum, respectively. Our proposed method, which employs the U-Net structure, is highly accurate and reproducible for automated ROI segmentation. This provides a foundation to improve automatic delineation of the boundaries between the target and surrounding normal soft tissues on a standard radiation therapy planning CT scan.

physics.med-ph